AAAAAA
Results:
1-16
|
Results: 16
Authors:
Garcia-Echevarria, C
Imbach, P
France, D
Furst, P
Lang, M
Noorani, M
Scholz, D
Zimmermann, J
Furet, P
Citation: C. Garcia-echevarria et al., A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome, BIOORG MED, 11(10), 2001, pp. 1317-1319
Authors:
Furet, P
Imbach, P
Furst, P
Lang, M
Noorani, M
Zimmermann, J
Garcia-Echeverria, C
Citation: P. Furet et al., Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design, BIOORG MED, 11(10), 2001, pp. 1321-1324
Authors:
Creutzig, U
Berthold, F
Boos, J
Fleischhack, G
Gadner, H
Gnekow, A
Graubner, U
Henze, G
Hermann, J
Imbach, P
Jurgens, H
Kabisch, H
Korholz, D
Niemeyer, CM
Reinhardt, D
Reiter, A
Ritter, J
Spaar, HJ
Zimmermann, M
Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185
Authors:
Imbach, P
Citation: P. Imbach, Presidential message to the Congress of the European Society for Paediatric Haematology and Immunology ESPHI in Lucerne, Switzerland, June 17-19, 2001, PEDIAT RES, 49(6), 2001, pp. 871-871
Authors:
Foster, CB
Zhu, SX
Erichsen, HC
Lehrnbecher, T
Hart, ES
Choi, E
Stein, S
Smith, MW
Steinberg, SM
Imbach, P
Kuhne, T
Chanock, SJ
Citation: Cb. Foster et al., Polymorphisms in inflammatory cytokines and Fc gamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study, BR J HAEM, 113(3), 2001, pp. 596-599
Authors:
Imbach, P
Capraro, HG
Furet, P
Mett, H
Meyer, T
Zimmermann, J
Citation: P. Imbach et al., 2,6,9-trisubstituted purines: Optimization towards highly potent and selective CDK1 inhibitors (vol 9, pg 91, 1999), BIOORG MED, 10(9), 2000, pp. 1001-1001
Authors:
Furet, P
Zimmermann, J
Capraro, HG
Meyer, T
Imbach, P
Citation: P. Furet et al., Structure-based design of potent CDK1 inhibitors derived from olomoucine, J COMPUT A, 14(5), 2000, pp. 403-409
Authors:
Kuhne, T
Di Gallo, A
Avoledo, P
Imbach, P
von Schweinitz, D
Hefti, F
Citation: T. Kuhne et al., Pediatric hematology and oncology at the University Children's Hospital, Basel, Switzerland, PED HEM ONC, 17(1), 2000, pp. 15-19
Authors:
Imbach, P
Kuhne, T
Citation: P. Imbach et T. Kuhne, Sequelae of treatment of ITP with anti-D (Rh-o) immunoglobulin, LANCET, 356(9228), 2000, pp. 447-448
Authors:
Kuhne, T
Staehelin, F
Avoledo, P
Tichelli, A
Passweg, J
Imbach, P
Gratwohl, A
Citation: T. Kuhne et al., Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumours: first experience, SCHW MED WO, 130(12), 2000, pp. 419-425
Authors:
Kuhne, T
Berchtold, W
Van Be, T
Van Binh, T
Imbach, P
Citation: T. Kuhne et al., Ethnicity and environment may affect the phenotype of immune thrombocytopenic purpura in children, PEDIAT RES, 48(3), 2000, pp. 374-379
Authors:
Imbach, P
Capraro, HG
Furet, P
Mett, H
Meyer, T
Zimmermann, J
Citation: P. Imbach et al., 2,6,9-trisubstituted purines: Optimization towards highly potent and selective CDK1 inhibitors, BIOORG MED, 9(1), 1999, pp. 91-96
Authors:
Kuhne, T
Imbach, P
Marbet, GA
Caliezi, C
Devay, J
Citation: T. Kuhne et al., Continuous infusion of von Willebrand factor and factor VIII after elective heart surgery in a 12-year-old girl with von Willebrand disease type 3, PED HEM ONC, 16(6), 1999, pp. 551-556
Authors:
Kuhne, T
Imbach, P
Citation: T. Kuhne et P. Imbach, Management of children with acute and chronic immune thrombocytopenic purpura, TRANSFUS SC, 19(3), 1998, pp. 261-268
Authors:
Imbach, P
Citation: P. Imbach, Chronic immune thrombocytopenic purpura: diagnosis and treatment in children, GEMATOL TR, 43(3), 1998, pp. 27-27
Authors:
Kuhne, T
Imbach, P
Citation: T. Kuhne et P. Imbach, Chronic immune thrombocytopenic purpura in childhood, SEM THROMB, 24(6), 1998, pp. 549-553
Risultati:
1-16
|